An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan
© Yeh et al; licensee BioMed Central Ltd. 2011
Received: 20 May 2011
Accepted: 6 September 2011
Published: 6 September 2011
Fatigue among cancer patients has often been reported in the literature; however, great variations have been documented, ranging from 15% to 90%, probably due to the lack of a widely accepted definition and established diagnostic criteria for cancer-related fatigue. The objective of this study was to evaluate the proposed International Statistical Classification of Diseases and Related Health Problems (10th revision) (ICD-10) criteria in a sample of cancer patients from a medical center and a regional teaching hospital in northern Taiwan. More accurate prevalence estimates of CRF may result in improved diagnoses and management of one of the most common symptoms associated with cancer and its treatment.
Since self-reporting from patients is the most effective and efficient method to measure fatigue, the ICD-10 criteria for fatigue were used. The ICD-10 criteria questionnaire was translated into Chinese and was approved by experts. Patients were recruited from outpatient palliative and oncology clinics and from palliative and oncology inpatient units.
Of the 265 cancer patients that were interviewed between 21 October 2008 and 28 October 2009, 228 (86%) reported having at least 2 weeks of fatigue in the past month, and further evaluation with the ICD-10 criteria showed that 132 (49.8%) had cancer-related fatigue. Internal consistency was very good, which was indicated by a Cronbach alpha of 0.843.
The prevalence of diagnosable CRF in the patients in this sample, of whom most were under palliative treatment, was 49.8%, which was probably somewhat lower than in some of the previous reports that have used less-strict criteria. In addition, among the various criteria of the proposed diagnostic criteria, the most frequently reported symptoms in our sample populations were regarding sleep disturbance and physical factors. Although they will require further replication in other samples, these formal diagnostic criteria can serve as a step toward a common language and a better understanding of the severity range of CRF.
Keywordsfatigue prevalence diagnosis cancer
Fatigue is the most common symptom or complaint related to cancer and cancer therapy , and has been identified as the most distressful symptom of cancer patients . Cancer-related fatigue (CRF) profoundly affects the quality of life (QOL) of both the patients and their families, physically and psychosocially, as well as in economic and occupational areas .
Cancer-associated fatigue is defined as a subjective state of overwhelming sustained exhaustion and decreased capacity for physical and mental work, which is not relieved by rest . CRF differs from the fatigue that accompanies everyday life, which is usually temporary and relieved by rest. In addition to the direct impact of cancer, various treatment modalities, particularly chemotherapy and radiation, are known to cause fatigue for many patients for an extended period of time. Fatigue caused by cancer or cancer therapy had been proposed for recognition by the World Health Organization (WHO) and for publication in the International Statistical Classification of Diseases and Related Health Problems (10th revision) (ICD-10) . Previous studies have varied in their reports of the prevalence of fatigue in cancer patients. Although not based on formal diagnostic criteria, between 58% and 90% of patients receiving cancer therapy have reported experiencing fatigue [6, 7]. The reported prevalence of fatigue in patients with advanced cancer has ranged from 51% to 89% [8, 9]. Typically, a cancer patient need only say that he or she is experiencing fatigue to be considered to have CRF. Therefore, existing prevalence estimates may be high and non-discriminating. Current prevalence estimates may combine both patients with everyday fatigue and those who have more clinically significant, definable CRF.
Proposed (1998 draft) ICD-10 Criteria for Cancer-Related Fatigue
Six (or more) of the following symptoms have been present every day or nearly every day during the same 2-week period in the past month, and at least one of the symptoms is (A1) significant fatigue.
A1. Significant fatigue, diminished energy, or increased need to
rest, disproportionate to any recent change in activity level
A2. Complaints of generalized weakness or limb heaviness
A3. Diminished concentration or attention
A4. Decreased motivation or interest to engage in usual activities
A5. Insomnia or hypersomnia
A6. Experience of sleep as unrefreshing or nonrestorative
A7. Perceived need to struggle to overcome inactivity
A8. Marked emotional reactivity (eg, sadness, frustration,
or irritability) to feeling fatigued
A9. Difficulty completing daily tasks attributed to feeling fatigued
A10. Perceived problems with short-term memory
A11. Postexertional malaise lasting several hours
B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning
C. There is evidence from the history, physical examination, or laboratory
findings that the symptoms are a consequence of cancer or cancer therapy.
D. The symptoms are not primarily a consequence of comorbid psychiatric
disorders such as major depression, somatization disorder, somatoform disorder, or delirium.
Participants and Settings
Data about cancer patients suspected to be fatigued were recruited from outpatient oncology and palliative clinics and oncology and palliative inpatient units at a medical center and a district teaching hospital in northern Taiwan. Selection criteria required that patients have a pathological diagnosis of cancer, be at least 18 years old, and be able to communicate in Mandarin or Taiwanese. Patients were excluded if they were cognitively impaired, if they refused to participate, or if they could not understand the intent of this study. A final sample of 265 patients was recruited for this study. Fatigue was assessed using the proposed ICD-10 criteria for cancer-related fatigue. Other data collected included demographics (sex, age), educational level, history of disease (type of tumor), staging of disease, and current treatment (e.g., curative treatment, palliative treatment, chemotherapy, radiotherapy, etc.). Written consent was given before the assessment of CRF.
This study was reviewed and approved by the Institutional Review Board of Mackay Memorial Hospital and Cardinal Tien Hospital.
The International Classification of Diseases recently included diagnostic nomenclature for CRF. These criteria have been proposed as a draft of a structured interview guide to help ensure the diagnosis of CRF, and were made in a standardized way across research and clinical applications by Dr. Cella . In 2005, several researchers validated the use of the proposed ICD-10 criteria for fatigue through comparison with other scales, namely the FACT-F and VAS, and discovered that the internal consistency of P-ICD 10 criteria was very good, with an alpha coefficient of 0.82, and concluded that the ICD-10 criteria can be recommended as a diagnostic tool for cancer-related fatigue . We were authorized by Dr. Cella to use the diagnostic interview guide for CRF, and its Chinese-language version, for application in a clinical and research setting to determine the prevalence of CRF in Taiwan.
Diagnostic interview guide for cancer-related fatigue
Diagnostic Interview Guide for Cancer-Related Fatigue
NOTE: Capitalized text represents instructions to the interviewer. Text in quotations represents statements to be read verbatim to respondent.
1 "Over the past month, has there been at least a 2-week period when you had significant fatigue, a lack of energy, or an increased need to rest every day or nearly every day?"
IF NO, STOP HERE. IF YES, CONTINUE
"For each of the following questions, focus on the worst 2 weeks in the past month (or else tha past 2 weeks if you felt equally fatigued for the entire month)."
2. "Did you feel weak all over or heavy all over? (every day or nearly every day?)"
3. "Did you have trouble concentrating or paying attention? (every day or nearly every day?)"
4. "What about losting your interest or desire to the things you usually do? (every day or nearly every day?)"
5. "How were you sleeping? Did you have trouble falling asleep, staying asleep, or waking too early? Or did you find yourself sleeping too much compared to what you usually sleep? (every day or nearly every day?)"
6. "Have you found that you usually don't feel rested or refreshed after you have slept? (every day or nearly every day?)"
7. "Did you have struggle or push yourself to do anything? (every day or nearly every day?)"
8. "Did you find yourself feeling sad, frustrated, or irritable because you felt fatigued? (every day or nearly every day?)"
9. "Did you have difficulty finishing something you had started to do because of feeling fatigued? (every day or nearly every day?)"
10. "Did you have trouble remembering things? For example, did you have trouble remembering where your keys were or what someone had told you a little while ago? (every day or nearly every day?)"
11. "Did you find yourself feeling sick or unwell for several hours after you had done something that took some effort(every time or nearly every time?)"
IF LESS THAN SIX ITEMS INCLUDING #1 ARE MARKED YES, STOP HERE.
12. "Has fatigue made it hard for you to do your work, take care of things at home, or get along with other people?"
IF #12 IS NO, STOP HERE
13. IS THERE EVIDENCE FROM THE HISTORY, PHYSICAL
EXAMINATION, OR LABORATORY FINDINGS THAT THE SYMPTOMS ARE A CONSEQUENCE OF CANCER OR CANCER TREATMENT?
IF #13 IS NO, STOP HERE
14. ARE THE SYMPTOMS PRIMARILY A CONSEQUENCE OF CO-MORBID PSYCHIATRIC DISORDERS SUCH AS MAJOR DEPRESSION, SOMATIZATION DISORDER, SOMATOFORM DISORDER, OR DELIRIUM?
IF #14 IS YES, PATIENT DOES NOT MEET CRITERIA FOR CANCER-RELATED FATIGUE
IF #14 IS NO, PATIENT MEETS CRITERIA FOR CANCER-RELATED FATIGUE
Prior to the data collection for the current study, the coordinator of this study (Y.L.) met the interviewers of this study (E.Y, Y.T., and W.S.) for training purposes. The training involved a review of the diagnostic criteria, the completion of simulated interviews, and the completion of actual interviews conducted with patients who were not participants of this study. The interviews of this study were conducted by 2 physicians and 1 nurse who was also currently a graduate student. They were all experienced in working with cancer patients. Sixteen interviews were tape-recorded for the purpose of determining inter-rater reliability. Ratings obtained from the interviewers were compared with those from the independent rater (S.L.) who was trained for the administration of the interviews but not involved in the data collection of this study. The level of the overall agreement between the study interviewers and the independent rater regarding the presence/absence of cancer-related fatigue was 95%. After calculation, we obtained that the coefficient of kappa, a measurement adjusted for base rates, was 0.88. The level of the overall agreement between the study interviewers and the independent rater regarding the presence/absence of the 14 individual criteria that comprise the diagnostic interview guide for Cancer-Related Fatigue (kappa = 0.96) was 90%. According to the rule of thumb, values of Kappa from 0.40 to 0.59 are considered moderate, 0.60 to 0.79 substantial, and 0.80 outstanding (Landis & Kochi, 1977). Most statisticians prefer Kappa values to be at least 0.6 and most often higher than 0.7 before claiming a good level of agreement.
A pretest was performed in which 21 Chinese-language versions of the diagnostic interview guide were completed before the study. Descriptive statistics were computed per patient group as P-ICD-positive or P-ICD-negative. Internal consistency of the P-ICD-10 was assessed by computing Cronbach's alpha coefficient. The correlations of each question were examined, and the values of the alpha coefficient showed medium strength correlations (ranging from 0.11 to 0.3). These indicated the instrument is a reliable tool for measuring fatigue.
P-ICD 10-positive(N = 132)
P-ICD 10-negative(N = 133)
Did not receive education
Head & Neck
Lung & Mediastinum
GI tract(except liver)
F/U after curative treatment
Condition of the Disease
No signs and symptoms
Progression (local invasion)
Patients who endorsed category A criteria (N = 265)
A1 Two weeks of fatigue in past month
A2 General weakness
A3 Trouble concentrating
A4 Decreased motivation
A6 Nonrestorative sleep
A7 Having to push things
A8 Sadness or frustration
A9 Trouble completing daily tasks
A10 Short-term memory problems
A11 Postexertional malaise
Patients who endorsed multiple symptoms (Criteria A) and Criteria B (N = 265)
Multiple Symptoms Reports
Did not responded to A1
Only responded A2
A1 + any 1
A1 + any 2
A1 + any 3
A1 + any 4
A1 + any 5 + B*
A1 + any 6 + B
A1 + any 7 + B
A1 + any 8 + B
A1 + any 9 + B
A1 + any 10 + B
A1 + any 5 or more but does not responded to B
Internal consistency of the P-ICD-10
Occurrences of each P-ICD 10 symptoms classified as positive and negative
P-ICD 10 positive
P-ICD 10 negative
A2 General weakness
A3 Trouble concentrating
A4 Decreased motivation
A6 Nonrestorative sleep
A7 Having to push things
A8 Sadness or frustration
A9 Trouble completing daily tasks
A10 Short-term memory problems
A11 Post-exertional malaise
According to the design of the questionnaire, the 1st question, which corresponds to the A1 criteria of the P-ICD-10 criteria, should be answered "yes" in order for the questionnaire to proceed, thereby resulting in the non-discriminating property of this general symptom. Of the 10 other complaints, the most frequently reported by both P-ICD 10-positive and P-ICD 10-negative patients were "general weakness", "insomnia or hypersomnia", "experience of sleep as unrefreshing or non-restorative", and "perceived problems with short-term memory". The most discriminative complaints were related to physical fatigue, and they are listed according to the order of their discriminative properties: "Difficulty completing daily tasks attributed to feeling fatigued" (P-ICD 10-positive 76%, negative 19.9%), "Perceived need to struggle to overcome inactivity" (P-ICD 10-positive 70.5%, negative 16.2%), and "Post-exertional malaise lasting several hours" (P-ICD 10-positive 72.9%, negative 21.3%). The least discriminating of the complaints was about sleep quality, which is the 5th question on the questionnaire: "insomnia or hypersonmia".
Internal consistency was established by calculating Cronbach alpha coefficients, which were 0.843, indicating good internal consistency for the Chinese-language version of the P-ICD 10 criteria. Removing non-reliable items would increase internal consistency. The alpha coefficient did not increase after removing any individual item, removing any item decreased the internal consistency, and the most reliable items, aside from the 1st symptom, were the 7th, 9th, and 2nd symptom, respectively.
To guarantee cultural equivalence and to establish expert validity, 7 authoritative specialists in the field of nursing, oncology, radio-oncology, psychiatry, and linguistics were formed to examine the Chinese-language version of the P-ICD 10 criteria. The experts were asked to rate the relevance of the content independently using a content validity index (CVI). They were asked to rate each item on the Chinese-language versions of the diagnostic interview guide based on relevance and semantic equivalence using the following 4-point Likert scale: 1 = not relevant (not appropriate), 2 = somewhat relevant (somewhat appropriate), 3 = relevant (quite appropriate), 4 = very relevant (very appropriate). The CVI was then computed based on the percentage of total items rated by the experts as either 3 or 4. According the Norwood(2000), a CVI rating exceeding .80 can be considered to show good content validity. All items in the Chinese-language versions of the diagnostic interview guide were rated by the panel experts as having a CVI greater than .90. For the final version, the CVIs for relevance and semantic equivalence both reached .99.
Fatigue is an important and one of the most prevalent complaints of cancer patients both during and after treatment , and previous reports demonstrated that the prevalence of cancer fatigue is up to 90% . In this study, 86% of patients reported significant fatigue, which is the first question of the questionnaire, indicating that it is a very common symptom for Taiwanese cancer patients. This result is consistent with other studies. The prevalence of CRF was studied in 2 national surveys conducted by Fatigue Coalitions, which studied 419 and 197 cancer patients, and showed an overall 74% of patients reporting fatigue . Another large-scale survey of 379 cancer patients who had received chemotherapy with or without radiation therapy showed fatigue was present in 75% of patients, with patients reporting fatigue as the symptom that most affected QOL, followed by nausea, depression, and pain . In another study, 58% of a sample of cancer patients receiving cancer therapy reported that fatigue had affected them in the past month, and that fatigue affected them significantly more than any other cancer symptom . In addition, another study reported that up to 75% of advanced-cancer patients suffered from significant fatigue . These results indicated that fatigue is a prevalent symptom related to cancer and cancer therapy. However, cancer fatigue is often underestimated as the oncologist's attention is focused primarily on tumor-related parameters such as disease-free survival or on treatable symptoms such as pain . This situation is explained by a lack of communication between physician and patient regarding fatigue . The lack of interest in fatigue as a topic for research has also been attributed to the lack of any effective treatment strategy . A survey of 470 health care personnel from various clinical areas demonstrated their poor knowledge and practice regarding fatigue assessment and management .
Another reason for the lack of interest in research on CRF is the lack of validated and clinically easy-to-use assessment tools . Similar to pain, fatigue is commonly conceptualized as a multidimensional sensation that incorporates sensory, cognitive, affective, behavioral, and physiologic components . However, unlike pain, no universally accepted definition or well-conceptualized dimensions for fatigue have been proposed . Although a multidimensional measurement may seem appropriate, and there are currently numerous multidimensional scales available, those scales may be too long for fatigued patients to complete and are therefore not suitable for clinical use. Moreover, unidimensional scales such as the BFI may not capture the multiple dimensions of fatigue and therefore are more suitable for screening or measuring the intensity of fatigue. This picture supports the need for reliable instruments to diagnose and assess cancer-related fatigue. Since the P-ICD-10 criteria have good internal consistency and can be recommended as a diagnostic tool , they were used with 265 patients in 2 clinical centers in Taiwan. The P-ICD-10 is structured as a multidimensional instrument and the present results confirm its good internal consistency with an alpha coefficient of 0.843 with all individual items being reliable. "Insomnia or hypersomnia", showed the lowest correlation with the other items, though it is also one of the most frequently reported symptoms of both ICD-10-positive and ICD-10-negative symptoms.
Although 86% of our patients reported fatigue, further investigation using the P-ICD-10 criteria demonstrated a significantly lower percentage (48.6%), as compared with currently reported estimates of CRF, which range from 60% to 90%. However, unlike all other previous studies that provide the percentage of individuals who reported any degree of fatigue, regardless of its impact on functioning, this study required that there be significant fatigue-related problems and disruption in daily functioning to assign the diagnosis. Thus, we distinguished between fatigue as a symptom reported by the vast majority of people with cancer, and CRF as a diagnostic entity.
The most frequently reported symptom of our sample population, whether the patients were classified as having CRF or not, was that of the 6th question in the questionnaire, which corresponds to criteria A6 of the P-ICD-10, "experience of sleep as unrefreshing or non-restorative", and it was also the symptom most frequently reported by both the P-ICD 10 positive and negative patients. Sleep disturbance associated with fatigue is often difficult to treat and manage. It may be influenced by numerous factors, including daytime naps, depression, anxiety, certain medications, tumor pain, sleep disruption on account of increased urination or hot flushes, and evening food and beverage intake. Although sleep disturbance is common in patients with cancer, it has been evaluated in few studies. In a pilot study of women receiving adjuvant chemotherapy for breast cancer, stimulus control (i.e., having a consistent time to lie down and get up, avoiding caffeine and stimulating activity in the evening) and sleep restriction (i.e., avoiding long or late afternoon naps, limiting time in bed to the normal hours of sleep only) significantly improved fatigue . The benefit of a multimodality sleep hygiene program was suggested in a controlled study of 2 different interventions (relaxation techniques or autogenic training) for up to 6 months; compared with the control group, both intervention groups had significantly better sleep latency, sleep duration, and daytime functioning . In addition, cognitive-behavioral therapy and stress reduction also may help insomnia and sleep disorder .
The 2nd most frequently reported symptom among our sample patients, whether they were diagnosed as having CRF or not, was that of the 2nd question on the questionnaire, "complaints of generalized weakness or limb heaviness". With an incidence of 65%, which was related to physical fatigue, it was also the 2nd most frequently reported symptom by both the P-ICD-10-positive and negative patients. In addition, the most discriminating complaints were also related to physical fatigue, such as "difficulty completing daily tasks attributed to feeling fatigue", "perceived need to struggle to overcome inactivity", and "post-exertional malaise lasting several hours". This indicated that physical issues are important factors in fatigue among cancer patients, and the incidence is even higher for patients who met the P-ICD-10 criteria. Quite a number of previous studies identified a decrease in activity level and muscle power related to cancer patients . A consistent decrease in the amount of daily activity could eventually lead to a reduced tolerance for normal activity and result in high levels of fatigue. The specific mechanism causing such a phenomenon remains essentially unknown. Current theory links cancer asthenia with a similar mechanism purported to play a role in producing the anorexia-cachexia syndrome, and the profound fatigue and fever associated with some infectious diseases. An immune response to the tumor resulting in activation of macrophages and the release of cytokines, such as tumor necrosis factor, IL-1, IL-6, and interferon-r, is central to the current model, as is the release of tumor by-products [27, 28]. Exercise has been shown to have the strongest evidence of benefit . A structured aerobic exercise program has been shown in several trials to reduce fatigue and emotional distress and to improve quality of life in cancer patients who exercised during treatment. Exercise regimens usually included walking or cycling [30–32]. According to NCCN guidelines for the management of CRF, exercise is the intervention with the most supporting evidence for effectiveness (category 1).
Fatigue is a multidimensional symptom. It may lead to influences on physical, psychological, spiritual and the social field. However, even now, the cause of fatigue cannot be readily identified, and it is difficult to properly diagnose the symptom. Thus there is no specific treatment for fatigue. And possible influential factors cannot be removed to ease the symptom and show curative effect. We could only reduce the symptom and provide the psychosocial and spiritual support for those with CRF. For the patients with fatigue, we recruit them for the holistic approach of palliative care which includes psychosocial and spiritual approach and psycho-oncology consultation. As for those with progressive fatigue, trials with Steroids and Ritalin were applied with some subjective response. The symptom management also includes non-pharmacological intervention, such as exercise, stress reduction, counseling, and psychosocial support. Complementary and alternative medicine such as Chinese Medicine might play some roles in fatigue management and should be studied in the future. The development of guidelines for managing fatigue in cancer patients depends on continued progress in understanding its pathophysiology and many contributing factors, and we believe the treatment of fatigue will be optimized by proper diagnosis, and a comprehensive strategy will probably produce the best results given the many causes of fatigue and its multidimensional manifestation.
The results of this study should be interpreted with caution because of certain limitations. There is a possibility that the sample of patients studied is not representative of the general population of Taiwan cancer patients, since the patients recruited were from northern Taiwan. Moreover, patients with cognitive impairment and poor communication skills were excluded, and this may result in underestimation of the prevalence of fatigue.
In conclusion, the P-ICD-10 criteria for CRF have good internal consistency, and are a reliable and clinically easy-to-use measurement of fatigue in Taiwanese cancer patients. In addition, our results showed a high incidence of fatigue among our sample of cancer patients, mostly due to sleep disturbances and physical factors. Further investigation of the management of fatigue, including pharmaceutical, psychological or physical treatment, is greatly needed. It is our hope that the refining and use of these diagnostic criteria will help better support CRF research and clinical management, and improve communication between patients and clinicians.
- Valentine AD, Meyers CA: Cognitive and mood disturbance as a cause and symptoms of fatigue in cancer patients. Cancer. 2001, 92: 92-1698. 10.1002/1097-0142(20010701)92:1<92::AID-CNCR1296>3.0.CO;2-W.View ArticleGoogle Scholar
- Schwartz AL, Nail LM, Chen S, Meek P, Barsevick AM, King ME, Jones LS: Fatigue patterns observed in patients receiving chemotherapy in radiotherapy. Cancer Invest. 2000, 18: 18-11.View ArticleGoogle Scholar
- Gupta D, Lis CG, Grutsch JF: The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage. 2007, 34: 40-10.1016/j.jpainsymman.2006.10.012.View ArticlePubMedGoogle Scholar
- Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W: Progress toward guidelines for the management of fatigue. Oncology. 1998, 12: 369-77.PubMedGoogle Scholar
- World Health Organization (1992) International Statistical Classification of Diseases and Related Health Problems, 1989 revision (pre-release draft, June 2003). World Health Organization, GenevaGoogle Scholar
- Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N: Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-center patient survey. Ann Oncol. 2000, 11: 971-975. 10.1023/A:1008318932641.View ArticlePubMedGoogle Scholar
- Nail M, Jones LS, Greene D, Schipper DL, Jensen R: Use and perceived activity of self-care activities in patients receiving chemotherapy. Oncol Nurs Forum. 1991, 18 (5): 883-887.PubMedGoogle Scholar
- Vainio A, Auvinen A, with Members of the Symptom Prevalence Group: Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage. 1996, 12: 12-10.View ArticleGoogle Scholar
- Coyle N, Adelhardt J, Foley KM, Portenoy RK: Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage. 1990, 5: 5-93.View ArticleGoogle Scholar
- Portenoy RK, Miaskowski C: Assessment and management of cancer-related fatigue. Principles and practice of supportive oncology. Edited by: Berger AM, Portenoy RK, Weissman DE. 1998, Lippincott-Williams & Wilkins, Philadelphia, 109-118. (eds)Google Scholar
- Cella D, Davis K, Breitbart W, Curt G: Cancer-related fatigue: prevalence of proposed diagnosed criteria in a United States sample of cancer survivors. J Clin Oncol. 2001, 19: 19-91.Google Scholar
- Bella SV, Paridaens R, Evers G: Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool Support Care Cancer. 2005, 13: 13-54.Google Scholar
- Servaes P, Verhagen C, Bleijenberg G: Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002, 38: 38-43.View ArticleGoogle Scholar
- Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L: The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: a comparison with the fatigue experienced by healthy individuals. Cancer Nurs. 1994, 17: 17-378.View ArticleGoogle Scholar
- Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997, 34: 4-PubMedGoogle Scholar
- Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ: Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist. 2000, 5: 353.Google Scholar
- Stone P, Hardy J, Broadly K, Tookman AJ, Kurowska A, A'Hern R: Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999, 79: 79-1486.Google Scholar
- Miller M, Kearney N: Nurses' knowledge and attitude towards cancer-related fatigue. Eur J Oncol Nurs. 2001, 5: 5-217. discussion 218-220View ArticleGoogle Scholar
- Stone P, Richards M, Hardy J: Fatigue in patients with cancer. Eur J Cancer. 1998, 34: 34-1676.View ArticleGoogle Scholar
- Hwang SS, Chang VT, Kasimis BS: A comparison of three fatigue measurement in veterans with cancer. Cancer Invest. 2003, 21: 21-373. 10.1081/CNV-120016400.View ArticleGoogle Scholar
- Piper BF: Measuring fatigue. Instruments for clinical research in health care. Edited by: Frank-Stromborg M, Olsen SJ, eds. 1997, Boston: Jones & Barlett, 482-496.Google Scholar
- Winningham ML, Nail LM, Burke MB, Broophy L, Cimprich B, Jones LS, Pickard-Holley S, Rhodes V, St Pierre B, Beck S: Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum. 1994, 21: 21-36.View ArticleGoogle Scholar
- Berger AM, VonEssen S, Khun BR, Piper BF, Farr L, Agrawal S, Lynch JC, Higginbotham P: Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 2002, 29: 1431-10.1188/02.ONF.1431-1441.View ArticlePubMedGoogle Scholar
- Simeit R, Deck R, Conta-Marx B: Sleep management training for cancer patients with insomnia. Support Care Cancer. 2004, 12: 176-10.1007/s00520-004-0594-5.View ArticlePubMedGoogle Scholar
- Given C, Given B, Rahbar M, Jeon S, McCorkle R, Cimprich B, Galecki A, Kozachik S, Brady A, Fisher-Malloy MJ, Courtney K, Bowie E: Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004, 22: 507-View ArticlePubMedGoogle Scholar
- Vestergaard S, Nayfield SG, Patel KV, Eldadah B, Cesari M, Ferrucci L, Ceresini G, Guralnik JM: Fatigue in a representative population of older persons and its association with functional impairment, functional limitation, and disability. J Gerontol A Biol Sci Med Sci. 2009, 64A: 76-82. 10.1093/gerona/gln017.View ArticlePubMed CentralGoogle Scholar
- Watanabe S, Bruera E: Anorexia and cachexia, asthenia, and lethargy. Hematol Oncol Clin North Am. 1996, 10: 189-206. 10.1016/S0889-8588(05)70334-8.View ArticlePubMedGoogle Scholar
- Beutler B, Cerami A: Cachetin: more than a tumor necrosis factor. N Engl J Med. 1987, 315: 379-85.Google Scholar
- Manzullo EF, Escalante CP: Research into fatigue. Hematol Oncol Clin North Am. 2002, 16: 619-628. 10.1016/S0889-8588(02)00012-6.View ArticlePubMedGoogle Scholar
- Mock V, Cameron L, Tompkins C: Every step counts: A walking exercise program for persons living with cancer. 1997, Baltimore, MD: Johns Hopkins UniversityGoogle Scholar
- MacVicar MG, Winningham ML, Nickel JL: Promoting the functional capacity of cancer patients. Cancer Bull. 1986, 338: 235-9.Google Scholar
- Mock V, Burke MB, Sheeham PK, Creaton EM, Winningham ML, Mckenney-Tedder S, Schwager LP, Liebman M: A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum. 1994, 21: 899-907.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/11/387/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.